Goldman Sachs’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.52M | Buy |
1,251,959
+297,079
| +31% | +$1.6M | ﹤0.01% | 3598 |
|
|
2025
Q4 | $6.07M | Buy |
954,880
+576,254
| +152% | +$4.01M | ﹤0.01% | 3566 |
|
|
2025
Q3 | $3.53M | Buy |
378,626
+197,200
| +109% | +$1.99M | ﹤0.01% | 3962 |
|
|
2025
Q2 | $2.61M | Sell |
181,426
-85,987
| -32% | -$849K | ﹤0.01% | 3969 |
|
|
2025
Q1 | $1.85M | Buy |
267,413
+96,333
| +56% | +$605K | ﹤0.01% | 4225 |
|
|
2024
Q4 | $908K | Buy |
171,080
+26,053
| +18% | +$143K | ﹤0.01% | 4885 |
|
|
2024
Q3 | $529K | Buy |
145,027
+69,559
| +92% | +$219K | ﹤0.01% | 5019 |
|
|
2024
Q2 | $206K | Sell |
75,468
-116,757
| -61% | -$391K | ﹤0.01% | 5256 |
|
|
2024
Q1 | $669K | Buy |
+192,225
| New | +$356K | ﹤0.01% | 4587 |
|
|
2022
Q4 | – | Sell |
-13,364
| Closed | -$16K | – | 6310 |
|
|
2022
Q3 | $16K | Sell |
13,364
-309,714
| -96% | -$498K | ﹤0.01% | 5972 |
|
|
2022
Q2 | $540K | Sell |
323,078
-32,280
| -9% | -$63.1K | ﹤0.01% | 5026 |
|
|
2022
Q1 | $874K | Sell |
355,358
-75,768
| -18% | -$207K | ﹤0.01% | 4934 |
|
|
2021
Q4 | $1.61M | Buy |
431,126
+78,834
| +22% | +$426K | ﹤0.01% | 4427 |
|
|
2021
Q3 | $2.21M | Sell |
352,292
-28,830
| -8% | -$238K | ﹤0.01% | 4105 |
|
|
2021
Q2 | $3.76M | Sell |
381,122
-86,191
| -18% | -$752K | ﹤0.01% | 3608 |
|
|
2021
Q1 | $4.37M | Buy |
467,313
+366,715
| +365% | +$2.91M | ﹤0.01% | 3250 |
|
|
2020
Q4 | $483K | Buy |
100,598
+14,415
| +17% | +$70.3K | ﹤0.01% | 4628 |
|
|
2020
Q3 | $345K | Buy |
86,183
+33,908
| +65% | +$164K | ﹤0.01% | 4664 |
|
|
2020
Q2 | $240K | Buy |
52,275
+6,163
| +13% | +$27.6K | ﹤0.01% | 4722 |
|
|
2020
Q1 | $150K | Buy |
46,112
+14,091
| +44% | +$54.1K | ﹤0.01% | 4810 |
|
|
2019
Q4 | $138K | Buy |
32,021
+3,159
| +11% | +$11.2K | ﹤0.01% | 4992 |
|
|
2019
Q3 | $114K | Buy |
28,862
+7,988
| +38% | +$34.1K | ﹤0.01% | 4948 |
|
|
2019
Q2 | $97K | Buy |
20,874
+1,640
| +9% | +$7K | ﹤0.01% | 4929 |
|
|
2019
Q1 | $81K | Buy |
+19,234
| New | +$69.3K | ﹤0.01% | 4948 |
|
|
2018
Q2 | – | Sell |
-229,405
| Closed | -$964K | – | 6087 |
|
|
2018
Q1 | $964K | Buy |
229,405
+214,439
| +1,433% | +$1.12M | ﹤0.01% | 4072 |
|
|
2017
Q4 | $88K | Buy |
+14,966
| New | +$80.8K | ﹤0.01% | 5783 |
|
|
2017
Q3 | – | Sell |
-182,633
| Closed | -$698K | – | 6902 |
|
|
2017
Q2 | $698K | Buy |
182,633
+163,817
| +871% | +$519K | ﹤0.01% | 4781 |
|
|
2017
Q1 | $51K | Hold |
18,816
| – | – | ﹤0.01% | 6283 |
|
|
2016
Q4 | $62K | Hold |
18,816
| – | – | ﹤0.01% | 6328 |
|
|
2016
Q3 | $56K | Sell |
18,816
-130,118
| -87% | -$478K | ﹤0.01% | 6436 |
|
|
2016
Q2 | $617K | Buy |
+148,934
| New | +$705K | ﹤0.01% | 4653 |
|
Other funds holding NAGE
SW
VCM
TCM
VPM